ALS

Nomakhosazana R Monnakgotla1, Amokelani C Mahungu1, Jeannine M Heckmann1

  • 1From the Neurology Research Group (N.R.M., A.C.M., J.M.H., M.N.), Division of Neurology, Department of Medicine; Neuroscience Institute (N.R.M., A.C.M., J.M.H., M.N.); Computational Biology Division (G.B., N.J.M.), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa; Center for Applied Bioinformatics (G.W., E.R., J.M.), St. Jude Children's Research Hospital, Memphis, TN; Department of Neuroscience (M.V.B.), Mayo Clinic, Jacksonville, FL; Center for Molecular Neurology (R.R.), University of Antwerp, Belgium; Department of Cell and Molecular Biology (J.P.T.), St. Jude Children's Research Hospital, Memphis, TN; and Department of Neurology (J.W., M.B.), University of Miami, FL.

Neurology. Genetics
|June 22, 2023
PubMed
概括

这项研究发现,SCAF4,SQSTM1,STMN2和SMN1/SMN2基因拷贝数的特定遗传变异与南非人的肌缩性侧面硬化症 (ALS) 风险之间没有关联. 这些发现强调了在遗传研究中需要多样化的种群.